Kidney Cancer Clinical Trials

1. (CGUK08061) A randomized phase II study of BEGF, RAF Kinase, mTOR Combination targeted therapy (CTT) with Bevacasizumab, Sorafenib, temsirolimus in advanced renal cell carcinoma.
2. (CGUK06001) A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma